Pulmonary complications of haematopoietic cell transplantation in children

Paediatric Respiratory Reviews

Volumn 8, Issue 1, 2007, Pages 46-61

  Michelson, Peter H ^a   Goyal, Rakesh ^a   Kurland, Geoffrey ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

bone marrow transplantation; bronchiolitis obliterans; children; complications; cytomegalovirus; obliterative bronchiolitis; pneumonia; stem cell transplantation

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CASPOFUNGIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; DEFIBROTIDE; FLUCONAZOLE; FLUDARABINE; FOSCARNET; GANCICLOVIR; GLUCOCORTICOID; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; LOMUSTINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; POSACONAZOLE; PREDNISONE; STEROID; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VISILIZUMAB; VORICONAZOLE;

BONE MARROW SUPPRESSION; BRONCHIOLITIS OBLITERANS; CHILD; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LUNG COMPLICATION; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG INFECTION; LUNG MYCOSIS; LUNG TOXICITY; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY VEIN OBSTRUCTION; RESPIRATORY DISTRESS SYNDROME; REVIEW; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES; RISK FACTORS;

EID: 34047120132     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.003     Document Type: Review

References (167)

1. Santos G.W. History of bone marrow transplantation. Clin Haematol 12 (1983) 611-639
2. Schretzenmayr A. Anamiebehandlung mit knochenmarksinjektionen. Klin Wochenschr 16 (1937) 1010-1012
3. Morrison M., and Samwick A.A. Intramedullary (sternal) transfusion of human bone marrow. J Am Med Assoc 115 (1940) 1708-1711
4. Yen K.T., Lee A.S., Krowka M.J., and Burger C.D. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med 25 (2004) 189-201
5. Jules-Elysee K., Stover D.E., Yahalom J., et al. Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. Am Rev Respir Dis 146 (1992) 485-491
6. Krowka M.J., Rosenow ECd, and Hoagland H.C. Pulmonary complications of bone marrow transplantation. Chest 87 (1985) 237-246
7. Garaventa A., Rondelli R., Castagnola E., et al. Fatal pneumopathy in children after bone marrow transplantation-report from the Italian Registry. Italian Association of Pediatric Hematology-Oncology BMT Group. Bone Marrow Transplant 16 (1995) 669-674
8. Garaventa A., Rondelli R., Castagnola E., et al. Pneumopathy in children after bone marrow transplantation. Report from the AIEOP-BMT Registry. The Italian Association of Pediatric Hematology-Oncology BMT Group. Bone Marrow Transplant 18 Suppl 2 (1996) 160-162
9. Griese M., Rampf U., Hofmann D., et al. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 30 (2000) 393-401
10. Siddiqui A.K., and Ahmed S. Pulmonary manifestations of sickle cell disease. Postgrad Med J 79 (2003) 384-390
11. Gladwin M.T., Sachdev V., Jison M.L., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease [see comment]. N Engl J Med 350 (2004) 886-895
12. Limper A.H. Chemotherapy-induced lung disease. Clin Chest Med 25 (2004) 53-64
13. Adamson I.Y. Drug-induced pulmonary fibrosis. Environ Health Perspect 55 (1984) 25-36
14. Abratt R.P., Morgan G.W., Silvestri G., and Willcox P. Pulmonary complications of radiation therapy. Clin Chest Med 25 (2004) 167-177
15. Rao K., Amrolia P.J., Jones A., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 105 (2005) 879-885
16. Robertson M.J., and Larson R.A. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 84 (1988) 233-239
17. Rousey S.R., Russler S., Gottlieb M., and Ash R.C. Low-dose Amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med 91 (1991) 484-492
18. Hoover M., Morgan E.R., and Kletzel M. Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med & Pediatr Oncol 28 (1997) 268-273
19. Wang J.-T., Yao M., Tang J.-L., et al. Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies. J Clin Oncol 19 (2001) 4000-4001
20. Barkan D., Nusair S., Resnick I.B., et al. Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleeding. Clin Transplant 18 (2004) 85-88
21. Cirino L.M., de Campos M., Samano M.N., et al. Diagnosis and treatment of mediastinal tumors by thoracoscopy. Chest 117 (2000) 1787-1792
22. Smith T.J., Rothenberg S.S., Brooks M., et al. Thoracoscopic surgery in childhood cancer. J Pediatr Hematol Oncol 24 (2002) 429-435
23. Isaac D.W., Parham D.M., and Patrick C.C. The role of esophagoscopy in diagnosis and management of esophagitis in children with cancer. Med Pediatr Oncol 28 (1997) 299-303
24. Eagle D.A., Gian V., Lauwers G.Y., et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 28 (2001) 59-62
25. Johansson J.E., Abrahmsson H., and Ekman T. Gastric emptying after autologous haemopoietic stem-cell transplantation: a prospective trial. Bone Marrow Transplant 32 (2003) 815-819
26. White M., Murphy A.J., Hastings Y., et al. Nutritional status and energy expenditure in children pre-bone-marrow-transplant. Bone Marrow Transplant 35 (2005) 775-779
27. Raynard B., Nitenberg G., Gory-Delabaere G., et al. Summary of the Standards, Options, and Recommendations for nutritional support in patients undergoing bone marrow transplantation. Br J Cancer 89 Suppl 1 (2003) S101-S106
28. Muscaritoli M., Grieco G., Capria S., et al. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 75 (2002) 183-190
29. Hopman G.D., Pena E.G., Le Cessie S., et al. Tube feeding and bone marrow transplantation. Med Pediatr Oncol 40 (2003) 375-379
30. Thornley I., Lehmann L.E., Sung L., et al. A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marro Transplant 10 (2004) 635-644
31. Chien J.W., Madtes D.K., and Clark J.G. Pulmonary function testing prior to hematopoietic stem cell transplantation. Bone Marrow Transplant 35 (2005) 429-435
32. Mello M., Tanaka C., and Dulley F.L. Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 32 (2003) 723-728
33. White A.C., Terrin N., Miller K.B., and Ryan H.F. Impaired respiratory and skeletal muscle strength in patients prior to hematopoietic stem-cell transplantation. Chest 128 (2005) 145-152
34. Kotloff R.M., Ahya V.N., and Crawford S.W. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir & Crit Care Med 170 (2004) 22-48
35. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27 Suppl 2 (2001) S3-S11
36. Murray J.C., Chiu J.K., Dorfman S.R., and Ogden A.K. Epiglottitis following preparation for allogeneic bone marrow transplantation. Bone Marrow Transplant 15 (1995) 997-998
37. Sonis S.T., Oster G., Fuchs H., et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19 (2001) 2201-2205
38. Chou R.H., Wong G.B., Kramer J.H., et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. Int J Radiat Oncol Biol Phys 34 (1996) 843-851
39. Blijlevens N.M., Donnelly J.P., and De Pauw B.E. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25 (2000) 1269-1278
40. Sonis S.T. The pathobiology of mucositis. Nat Rev Cancer 4 (2004) 277-284
41. Woo S.B., Sonis S.T., Monopoli M.M., and Sonis A.L. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72 (1993) 1612-1627
42. Whelan H.T., Buchmann E.V., Dhokalia A., et al. Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice. J Clin Laser Med Surg 21 (2003) 67-74
43. Khurshid I., and Anderson L.C. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J 78 (2002) 257-262
44. Alam S., and Chan K.M. Noninfectious pulmonary complications after organ transplantation. Curr Opin Pulm Med 2 (1996) 412-428
45. Cahill R.A., Spitzer T.R., and Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 18 (1996) 177-184
46. Ravoet C., Feremans W., Husson B., et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 18 (1996) 943-947
47. Capizzi S.A., Kumar S., Huneke N.E., et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 27 (2001) 1299-1303
48. Ravenel J.G., Scalzetti E.M., and Zamkoff K.W. Chest radiographic features of engraftment syndrome. J Thorac Imaging 15 (2000) 56-60
49. Crawford S.W. Noninfectious lung disease in the immunocompromised host. Respiration 66 (1999) 385-395
50. Kantrow S.P., Hackman R.C., Boeckh M., et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 63 (1997) 1079-1086
51. Clark J.G., Hansen J.A., Hertz M.I., et al. Idiopathic pneumonia syndrome after bone marrow transplantation: NHLBI Workshop Summary. Am Rev Respir Dis 147 (1993) 1601-1606
52. Shankar G., and Cohen D.A. Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol 82 (2001) 101-113
53. Shukla M., Yang S., Milla C., et al. Absence of host tumor necrosis factor receptor 1 attenuates manifestations of idiopathic pneumonia syndrome. Am J Physiol Lung Cell Mol Physiol 288 (2005) L942-L949
54. Schots R., Kaufman L., Van Riet I., et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 17 (2003) 1150-1156
55. Nusair S., Breuer R., Shapira M.Y., et al. Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation [see comment]. Eur Resp J 23 (2004) 440-445
56. Drew W.L., Finley T.N., and Golde D.W. Diagnostic lavage and occult pulmonary hemorrhage in thrombocytopenic immunocompromised patients. Am Rev Respir Dis 116 (1977) 215-221
57. Robbins R.A., Linder J., Stahl M.G., et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 87 (1989) 511-518
58. Metcalf J.P., Rennard S.I., Reed E.C., et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am J Med 96 (1994) 327-334
59. Heggen J., West C., Olson E., et al. Diffuse alveolar hemorrhage in pediatric hematopoietic cell transplant patients. Pediatrics 109 (2002) 965-971
60. Agusti C., Ramirez J., Picado C., et al. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. Am J Respir & Crit Care Med 151 (1995) 1006-1010
61. Troussard X., Bernaudin J.F., Cordonnier C., et al. Pulmonary veno-occlusive disease after bone marrow transplantation. Thorax 39 (1984) 956-957
62. Hackman R.C., Madtes D.K., Petersen F.B., and Clark J.G. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 47 (1989) 989-992
63. Trobaugh-Lotrario A.D., Greffe B., Deterding R., et al. Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. J Pediatr Hematol Oncol 25 (2003) 405-409
64. Wingard J.R., Mellits E.D., Jones R.J., et al. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients. Bone Marrow Transplant 4 (1989) 685-689
65. Coppell J.A., Brown S.A., and Perry D.J. Veno-occlusive disease: cytokines, genetics, and haemostasis. Blood Rev 17 (2003) 63-70
66. Mor E., Pappo O., Bar-Nathan N., et al. Defibrotide for the treatment of veno-occlusive disease after liver transplantation. Transplantation 72 (2001) 1237-1240
67. Centers for Disease Control Prevention, Infectious Diseases Society of America. American Society of Bone Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 6 (2000) 659-713 5; 7-27; quiz 29-33.
68. Hartmann O., Le Corroller A.G., Blaise D., et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 126 (1997) 600-607
69. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukaemia [see comment]. N Engl J Med 351 (2004) 2276-2285
70. Kook H., Goldman F., Padley D., et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 88 (1996) 1089-1097
71. Kook H., Goldman F., Giller R., et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin Diagn Lab Immunol 4 (1997) 96-103
72. Small T.N., Avigan D., Dupont B., et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant 3 (1997) 65-75
73. Noel D.R., Witherspoon R.P., Storb R., et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 51 (1978) 1087-1105
74. Witherspoon R.P., Storb R., Ochs H.D., et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 58 (1981) 360-368
75. Wingard J.R., and Annaissie E. Infectious complications after hematopoietic cell transplantation. In: Mehta P. (Ed). Pediatric Stem Cell Transplantation (2004), Jones and Bartlett Publishers, Boston 389-400
76. Collin B.A., Leather H.L., Wingard J.R., and Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33 (2001) 947-953
77. Klingspor L., Stintzing G., Fasth A., and Tollemar J. Deep Candida infection in children receiving allogeneic bone marrow transplants: incidence, risk factors and diagnosis. Bone Marrow Transplant 17 (1996) 1043-1049
78. Marr K.A., Seidel K., White T.C., and Bowden R.A. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 181 (2000) 309-316
79. Kremery V., and Barnes A.J. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50 (2002) 243-260
80. Wingard J.R. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 5 (1999) 55-68
81. Baran J., Muckatira B., and Khatib R. Candidemia before and during the fluconazole era: Prevalence, type of species and approach to teatment in a tertiary care community hospital. Scand J Infect Dis 33 (2001) 137-139
82. Berrouane Y.F., Herwaldt L.A., and Pfaller M.A. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 37 (1999) 531-537
83. Wingard J.R., and Leather H. A new era of antifungal therapy. Biol Blood Marrow Transplant 10 (2004) 73-90
84. Saral R., Burns W.H., Laskin O.L., et al. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 305 (1981) 63-67
85. Lundgren G., Wilczek H., Lonnqvist B., et al. Acyclovir prophylaxis in bone marrow transplant recipients. Scand J Infect Dis Suppl 47 (1985) 137-144
86. Ramsey P.G., Fife K.H., Hackman R.C., et al. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 97 (1982) 813-820
87. Ljungman P., Wilczek H., Gahrton G., et al. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant 1 (1986) 185-192
88. Ljungman P., Ellis M.N., Hackman R.C., et al. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. J Infect Dis 162 (1990) 244-248
89. Hovi L., Saarinen-Pihkala U.M., Vettenranta K., and Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 26 (2000) 999-1004
90. Martino R., Subira M., Rovira M., et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 116 (2002) 475-482
91. Jantunen E., Piilonen A., Volin L., et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 25 (2000) 867-871
92. Ho P.L., and Yuen K.Y. Aspergillosis in bone marrow transplant recipients. Crit Rev Oncol-Hematol 34 (2000) 55-69
93. Reichenberger F., Habicht J., Matt P., et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 24 (1999) 1195-1199
94. Williamson EC, Oliver DA, Johnson EM et al., Aspergillus antigen testing in bone marrow transplant recipients. [erratum appears in J Clin Pathol 2001; 54: 416]. J Clin Pathol 2000; 53:362-366.
95. Walsh T.J., Pappas P., Winston D.J., et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever [see comment]. N Engl J Med 346 (2002) 225-234
96. Herbrecht R., Denning D.W., Patterson T.F., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [see comment]. N Engl J Med 347 (2002) 408-415
97. Groll A.H., and Walsh T.J. Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Rev Anti Infect Ther 3 (2005) 467-487
98. Boeckh M., Nichols W.G., Papanicolaou G., et al. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9 (2003) 543-558
99. Holmberg L.A., Boeckh M., Hooper H., et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation [see comment]. Blood 94 (1999) 4029-4035
100. Chakrabarti S., Mackinnon S., Chopra R., et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution [see comment]. Blood 99 (2002) 4357-4363
101. Carpenter P.A., Lowder J., Johnston L., et al. A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 11 (2005) 465-471
102. Nash R.A., Dansey R., Storek J., et al. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 9 (2003) 583-591
103. Aspin M.M., Gallez-Hawkins G.M., Giugni T.D., et al. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol 32 (1994) 2266-2269
104. Watzinger F., Suda M., Preuner S., et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol 42 (2004) 5189-5198
105. Schvoerer E., Henriot S., Zachary P., et al. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma. J Med Virol 76 (2005) 76-81
106. Bueno J., Ramil C., and Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatr Drugs 4 (2002) 279-290
107. Han C.S., Miller W., Haake R., and Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 13 (1994) 277-283
108. Selby P.J., Powles R.L., Easton D., et al. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Br J Cancer 59 (1989) 434-438
109. Ormrod D., and Goa K. Valaciclovir: a review of its use in the management of herpes zoster. Drugs 59 (2000) 1317-1340
110. Tuan I.Z., Dennison D., and Weisdorf D.J. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 10 (1992) 267-272
111. Boeckh M. Pneumocystis carinii pneumonia: Current prevention and treatment strategies. Blood and Marrow Transplant Rev 13 (2003) 8-10
112. Miller R.F., and Semple S.J. Glucocorticoid therapy for severe Pneumocystis carinii pneumonia. J Infect 21 (1990) 131-137
113. Locksley R.M., Flournoy N., Sullivan K.M., and Meyers J.D. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 152 (1985) 1172-1181
114. Aucouturier P., Barra A., Intrator L., et al. Long lasting IgG subclass and antgibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 70 (1987) 779-785
115. Hoyle C., and Goldman J.M. Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 14 (1994) 247-252
116. Sullivan K.M., Leisenring W., Flowers M., et al. Determinants of late infection following marrow transplantation (MT) for aplastic anemia (AA) and myelodysplastic syndrome (MDS). Blood 86 Suppl 1 (1995) 213a
117. Atkinson K., Storb R., Prentice R.L., et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 53 (1979) 720-731
118. Engelhard D. Bacterial and fungal infections in children undergoing bone marrow transplantation. Bone Marrow Transplant 21 Suppl 2 (1998) S78-S80
119. Boeckh M., Leisenring W., Riddell S.R., et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101 (2003) 407-414
120. Shapira M.Y., Or R., Resnick I.B., et al. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant 32 (2003) 557-561
121. Couriel D., Canosa J., Engler H., et al. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant 18 (1996) 347-353
122. Wolf D.G., Lurain N.S., Zuckerman T., et al. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 101 (2003) 463-465
123. Nichols W.G., Corey L., Gooley T., et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98 (2001) 573-578
124. Marr K.A., Carter R.A., Boeckh M., et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100 (2002) 4358-4366
125. Alangaden G.J., Wahiduzzaman M., and Chandrasekar P.H. Bone Marrow Transplant G. Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease. Clin Infect Dis 35 (2002) 659-664
126. Bruno B., Gooley T., Hackman R.C., et al. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant 9 (2003) 341-352
127. Hale G.A., Heslop H.E., Krance R.A., et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23 (1999) 277-282
128. Carrigan D.R. Adenovirus infections in immunocompromised patients. Am J Med 102 (1997) 71-74
129. Kampmann B., Cubitt D., Walls T., et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 130 (2005) 595-603
130. Lion T., Baumgartinger R., Watzinger F., et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102 (2003) 1114-1120
131. Zerr D.M., Corey L., Kim H.W., et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40 (2005) 932-940
132. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (2001) 719-724
133. Williams J.V., Harris P.A., Tollefson S.J., et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children [see comment]. N Engl J Med 350 (2004) 443-450
134. Martino R., Porras R.P., Rabella N., et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 11 (2005) 781-796
135. Kindler T., Schindel C., Brass U., and Fischer T. Fatal sepsis due to mycobacterium tuberculosis after allogeneic bone marrow transplantation. Bone Marrow Transplant 27 (2001) 217-218
136. Hughes W.T. Mycobacterial infections in bone marrow transplant recipients. Biol Blood Marrow Transplant 6 (2000) 359-360
137. Yuen K.Y., and Woo P.C.Y. Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 20 (2002) 51-62
138. Budak-Alpdogan T., Tangun Y., Kalayoglu-Besisik S., et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 6 (2000) 370-374
139. Altclas J., Lescano A., Salgueira C., et al. Multidrug-resistant tuberculosis in bone marrow transplant recipient. Transplant Infect Dis 7 (2005) 45-46
140. Gaviria J.M., Garcia P.J., Garrido S.M., et al. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections [see comment]. Biol Blood Marrow Transplant 6 (2000) 361-369
141. Chow J.W., and Yu V.L. Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect 13 (1998) 132-139
142. Garbino J., Bornand J.E., Uckay I., et al. Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use. J Clin Pathol 57 (2004) 1302-1305
143. Lindsay DSJ, Abraham WH, Findlay W, et al. Laboratory diagnosis of legionnaires' disease due to Legionella pneumophila serogroup 1: comparison of phenotypic and genotypic methods. [erratum appears in J Med Microbiol. 2004; 53(Pt 5):457]. J Med Microbiol 2004; 53(Pt 3):183-187.
144. Dudek A.Z., Mahaseth H., DeFor T.E., and Weisdorf D.J. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 9 (2003) 657-666
145. Kurland G., and Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol 39 (2005) 193-208
146. Marras T.K., Chan C.K., Lipton J.H., et al. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 33 (2004) 509-517
147. Santo Tomas L.H., Loberiza Jr. F.R., Klein J.P., et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 128 (2005) 153-161
148. Lynch D.A., Travis W.D., Muller N.L., et al. Idiopathic interstitial pneumonias: CT features. Radiol 236 (2005) 10-21
149. Marras T.K., and Chan C.K. Obliterative bronchiolitis complicating bone marrow transplantation. Semin Respir and Crit Care Med 24 (2003) 531-542
150. Hayes-Jordan A., Benaim E., Richardson S., et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 37 (2002) 446-452
151. Sanchez J., Torres A., Serrano J., et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 20 (1997) 403-408
152. Khalid M., Al Saghir A., Saleemi S., et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study [see comment]. Eur Respir J 25 (2005) 490-493
153. Ratjen F., Rjabko O., and Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant 36 (2005) 135-138
154. Fullmer J.J., Fan L.L., Dishop M.K., et al. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics 116 (2005) 767-770
155. Wilczynski S.W., Erasmus J.J., Petros W.P., et al. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir & Crit Care Med 157 (1998) 565-573
156. Parish J.M., Muhm J.R., and Leslie K.O. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation. Mayo Clin Proc 78 (2003) 630-634
157. Afessa B., Litzow M.R., and Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 28 (2001) 425-434
158. Gosselin M.V., and Adams R.H. Pulmonary complications in bone marrow transplantation. J Thorac Imaging 17 (2002) 132-144
159. Curtis R.E., Travis L.B., Rowlings P.A., et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94 (1999) 2208-2216
160. Razonable R.R., and Paya C.V. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 10 (2003) 60-65
161. Orentas R.J., Schauer Jr. D.W., Ellis F.W., et al. Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients. Pediatr Transplant 7 (2003) 305-314
162. Presneill J.J., Nakata K., Inoue Y., and Seymour J.F. Pulmonary alveolar proteinosis. Clin Chest Med 25 (2004) 593-613 viii
163. Blazar B.R., and Murphy W.J. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci 360 (2005) 1747-1767
164. Vermylen C. Hematopoietic stem cell transplantation in sickle cell disease. Blood Rev 17 (2003) 163-166
165. Iwasaki T. Recent advances in the treatment of graft-versus-host disease. Clin 2 (2004) 243-252
166. Lee S.J. New approaches for preventing and treating chronic graft-versus-host disease. Blood 105 (2005) 4200-4206
167. Imado T., Iwasaki T., Kataoka Y., et al. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 104 (2004) 1542-1549